Related Experiment Video
Updated: Jul 6, 2025

07:58
Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
8.9K
Development of an adverse outcome pathway network for nephrotoxicity
D A Barnes1, J W Firman2, S J Belfield2
1Division of Pharmacology, Utrecht University, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands.
Archives of Toxicology
|January 10, 2024
Summary
Adverse outcome pathways (AOPs) networks model kidney toxicity. This study identified key events like mitochondrial dysfunction and oxidative stress, paving the way for new non-animal testing methods for chemical safety assessment.
Area of Science:
- Toxicology
- Computational Biology
- Biochemistry
Background:
- Adverse Outcome Pathways (AOPs) provide structured, evidence-based representations of chemical toxicity mechanisms.
- Linear AOPs often fail to capture complex toxicological processes, necessitating network approaches.
- AOP networks help understand chemical interactions and predict adverse outcomes in complex exposure scenarios.
Purpose of the Study:
- To develop an Adverse Outcome Pathway (AOP) network for nephrotoxicity by connecting thirteen individual AOPs.
- To identify key events (KEs) central to various kidney-related adverse outcomes.
- To establish a foundation for developing in vitro and in silico methods for assessing chemical-induced nephrotoxicity.
Main Methods:
- Utilized established criteria to construct an AOP network from the AOP-Wiki database, focusing on nephrotoxicity.
- Analyzed the topological features of the modelled AOP network.
- Identified central and highly connected Key Events (KEs) within the network.
Main Results:
- Successfully developed an AOP network linking thirteen individual AOPs related to nephrotoxicity.
- Identified mitochondrial dysfunction, oxidative stress, and tubular necrosis as the most connected and central KEs.
- These central KEs are linked to adverse outcomes such as kidney failure and chronic kidney disease.
Conclusions:
- The developed AOP network provides a comprehensive model for understanding chemical-induced nephrotoxicity.
- Central KEs like mitochondrial dysfunction and oxidative stress are critical targets for further research.
- This network approach supports the development of novel in vitro and in silico assays to replace animal testing for kidney toxicity assessment.
Keywords:
Adverse outcome pathwayKey eventsMolecular initiating eventNephrotoxicityNew approach methodologyMore Related Videos
Related Concept Videos
Pharmacovigilance
835
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
835
Renal Failure: Dose Adjustments
92
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
92
Toxic Reactions: Overview
978
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
978
Nephrons
2.5K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
2.5K
Protein Networks
4.0K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
432
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
432

